Year: 2018
Type: article
Abstract: // Xiang Song 1, 2, * , Yan Zhang 3, * , Li Zhang 2 , Wengang Song 4 and Lixin Shi 3 1 Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China 2 Comprehensive Ward, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China 3 Department of Endocrinology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China 4 Institute of Immunology, Taishan Medical University, Tai’an 271000, China * These authors have contributed equally to this work Correspondence to: Lixin Shi, email: [email protected] Keywords: dendritic cells; hypoxia; indoleamine 2,3-dioxygenase; adenosine; inflammation Received: September 12, 2017 Accepted: January 03, 2018 Published: January 09, 2018 ABSTRACT Hypoxia-associated metabolic reprogramming modulates the biological functions of many immune and non-immune cells, and affects immune response types and intensities. Adenosine and indoleamine 2,3-dioxygenase (IDO) are known immunosuppressors, and adenosine is a hypoxia-associated product. We investigated the impact of hypoxia on IDO production in dendritic cells (DCs). We found that hypoxia (1% O 2 ) enhances IDO production in DCs, and this increase was dependent on the adenosine A3 receptor (A3R), but not A2aR or A2bR. A3R blockade during hypoxia inhibited IDO production in DCs, while A2bR blockade further enhanced IDO production. Activating A2aR had no effect on IDO production. Hypoxia (1% O 2 ) upregulated CD86, CD274, HLA-DR, and CD54, and downregulated CD40 and CD83 in DCs as compared to normoxia (21% O 2 ). IDO inhibition in hypoxia-conditioned DCs reversed MHC-II, CD86, CD54, and CD274 upregulation, but further downregulated CD40 and CD83. Our findings offer guidance for pharmacological administration of adenosine receptor agonists or antagonists with the goal of achieving immune tolerance or controlling insulin resistance and other metabolic disorders via IDO modulation.
Source: Oncotarget
Authors: Xiang Song, Yan Zhang, Li Zhang, Wengang Song, Lixin Shi
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
Awards: 脾脏在肺脏树突状细胞更新中的作用与机制研究, G8183491515
OpenAlex ID: W2784249854
